These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 15906880)

  • 1. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico.
    Garfein RS; Laniado-Laborin R; Rodwell TC; Lozada R; Deiss R; Burgos JL; Cuevas-Mota J; Cerecer P; Moser K; Volker ML; Strathdee SA
    Emerg Infect Dis; 2010 May; 16(5):757-63. PubMed ID: 20409363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmatic management of multidrug resistant TB.
    Sarin R
    Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
    [No Abstract]   [Full Text] [Related]  

  • 3. XDR tuberculosis--implications for global public health.
    Raviglione MC; Smith IM
    N Engl J Med; 2007 Feb; 356(7):656-9. PubMed ID: 17301295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tuberculosis--still increasing threat. Time for mobilization over the national borders].
    Larsson LO
    Lakartidningen; 2009 Jul 22-Aug 4; 106(30-31):1882-3. PubMed ID: 19739439
    [No Abstract]   [Full Text] [Related]  

  • 5. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
    Keshavjee S; Farmer PE
    N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
    [No Abstract]   [Full Text] [Related]  

  • 6. Extensively drug-resistant tuberculosis. Recent outbreaks highlight the need for improved prevention, control, and surveillance programs.
    Todd B
    Am J Nurs; 2007 Jun; 107(6):29-31. PubMed ID: 17519597
    [No Abstract]   [Full Text] [Related]  

  • 7. Defusing the global timebomb.
    Reichman LB
    J Public Health Policy; 2005 Apr; 26(1):115-21. PubMed ID: 15906880
    [No Abstract]   [Full Text] [Related]  

  • 8. The DOTS strategy for controlling the global tuberculosis epidemic.
    Frieden TR; Munsiff SS
    Clin Chest Med; 2005 Jun; 26(2):197-205, v. PubMed ID: 15837105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis.
    Harries AD; Libamba E; Schouten EJ; Mwansambo A; Salaniponi FM; Mpazanje R
    BMJ; 2004 Nov; 329(7475):1163-6. PubMed ID: 15539674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA; Wright A
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emergence extensive drug resistance tuberculosis (XDR)].
    Vier H; Schaberg T; Gillissen A
    Pneumologie; 2007 Sep; 61(9):606-9. PubMed ID: 17729211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.
    Chiang CY; Caminero JA; Enarson DA
    Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.